Construction of trypanosome artificial mini-chromosomes

Area of Science:

• Molecular Biology
• Parasitology
• Genetics

Background:

• Trypanosoma brucei is a protozoan parasite responsible for human African trypanosomiasis.
• Genetic manipulation of T. brucei is crucial for understanding parasite biology and developing new therapies.
• The development of stable, extrachromosomal elements for genetic engineering in T. brucei has been a long-standing challenge.

Purpose of the Study:

• To engineer and characterize novel, stably inherited artificial mini-chromosomes in the procyclic form of Trypanosoma brucei.
• To assess the stability and maintenance of these artificial mini-chromosomes in the absence of drug selection.
• To establish a new platform for genetic manipulation and functional studies in T. brucei.

Main Methods:

• Design and synthesis of two linear DNA constructs (10 kb and 13 kb) containing a T. brucei PARP promoter, a chloramphenicol acetyltransferase (CAT) gene, and hygromycin phosphotransferase (Hph) genes, flanked by telomere and subtelomeric sequences.
• Electroporation of these linear DNA constructs into the procyclic form of T. brucei.
• Selection of hygromycin-B resistant cell lines.
• Analysis of the size, structure, and stability of the integrated DNA using molecular techniques.

Main Results:

• Successful generation of stable, linear DNA molecules, termed trypanosome artificial mini-chromosomes (TACs), in T. brucei.
• The input DNA constructs were maintained as linear molecules, bounded by telomeres, and increased in size (20-150 kb) due to the addition of new sequences, not tandem repeats.
• These TACs were stably inherited for at least 20 generations without drug selection.

Conclusions:

• The study successfully developed and characterized novel, stably inherited artificial mini-chromosomes (TACs) in Trypanosoma brucei.
• These TACs represent a significant advancement in the genetic engineering of T. brucei, providing a robust platform for future research.
• The findings open new avenues for functional genomics and drug target validation in this important human pathogen.